CP-67015 structure
|
Common Name | CP-67015 | ||
---|---|---|---|---|
CAS Number | 100325-51-7 | Molecular Weight | 330.28600 | |
Density | 1.424g/cm3 | Boiling Point | 496.7ºC at 760 mmHg | |
Molecular Formula | C17H12F2N2O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 254.2ºC |
Use of CP-67015CP-67015, a nalidixic acid analog, is a potent topoisomerase II inhibitor. CP-67015 is a positive direct-acting mutagen in mammalian cells with both gene and chromosomal level effects[1]. |
Name | 1-ethyl-6,8-difluoro-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid |
---|---|
Synonym | More Synonyms |
Description | CP-67015, a nalidixic acid analog, is a potent topoisomerase II inhibitor. CP-67015 is a positive direct-acting mutagen in mammalian cells with both gene and chromosomal level effects[1]. |
---|---|
Related Catalog | |
Target |
Topoisomerase II |
In Vitro | CP-67015 (10-100 μg/mL; 12-36 h) produces a drastic increase in chromosome damage in human lymphocytes and in CHO cells[1]. CP-67015 inhibits supercoiling activity of prokaryotic DNA gyrase, with 100% inhibition at the concentration of 4.0 μg/mL[1]. |
In Vivo | CP-67015 (a single dose 1000 mg/kg or 500 mg/kg/day for 5 days; i.p.) induces chromosome damage in male CD-1 mice in mouse bone marrow cells[1]. |
References |
Density | 1.424g/cm3 |
---|---|
Boiling Point | 496.7ºC at 760 mmHg |
Molecular Formula | C17H12F2N2O3 |
Molecular Weight | 330.28600 |
Flash Point | 254.2ºC |
Exact Mass | 330.08200 |
PSA | 72.19000 |
LogP | 3.05980 |
Vapour Pressure | 1.11E-10mmHg at 25°C |
Index of Refraction | 1.604 |
WGK Germany | 3 |
---|
3-Quinolinecarboxylic acid,1,4-dihydro-6,8-difluoro-1-ethyl-4-oxo-7-(4-pyridinyl) |
3-Quinolinecarboxylicacid,1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(4-pyridinyl) |
CP-67,015 |